(a) If more CEOs are targeted, it will modify their behaviour, and make them more likely to tone down their ruthlessness.

(b) There is already a lot of news coverage and attention on the horrific nature of U.S. healthcare. If some policies change more rapidly, then I think some might consider this killing an effective action in saving hundreds of lives.

I've worked in the space. Most people don't care about denials that are reasonable. I.e. escalation through "lets try these first drugs" when there isn't an established history of use. Ruling out less expensive problems before approving the most expensive operation. Thise aren't generally issues.

It's capricious denials happening over and over and over again, despite well established case history. Denials that clearly don't make sense. Prior Auths being used as financial "nudges".

That type of thing can screw right off. It's why I left the space after it proved absolutely impossible to get through to people that these measures were costing the lives of our customers. I bloody tried; and in the end, left for the sake of keeping what was left of my soul intact.

As far as I'm concerned the industry has made their bed. They can now sleep in it.

It's not simply approval or denial. In the US, you can still get health care for conditions the insurance company decides to deny payment for after the fact. The "insured" is then financially ruined. This is so exceedingly common in the US. It's far, far, far, far, far, far, far less likely to be financially destroyed by a health issue in the UK or any other industrialized nation.